Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma (Q33216729)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma |
scientific article |
Statements
1 reference
Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma (English)
1 reference
Alexander M M Eggermont
1 reference
Bernard Escudier
1 reference
Gerd Ritter
1 reference
Wim H J Kruit
1 reference
Heidi H van Ojik
1 reference
Vincent G Brichard
1 reference
Thierry Dorval
1 reference
Poulam Patel
1 reference
Nicolas van Baren
1 reference
Marie-Françoise Avril
1 reference
Sophie Piperno
1 reference
Amir Khammari
1 reference
Marguerite Stas
1 reference
Bernard Lethé
1 reference
Danièle Godelaine
1 reference
Francis Brasseur
1 reference
Yi Zhang
1 reference
Pierre van der Bruggen
1 reference
Thierry Boon
1 reference
Marie Marchand
1 reference
1 November 2005
1 reference
1 reference
117
1 reference
596-604
1 reference
1 reference
Identifiers
1 reference
1 reference